No Data
Guandian Defense (688287.SH) stocks will be subject to other risk warnings.
Announcement from Guandian Defense (688287.SH), the company found in self-inspection that, as of May 29, 2024, the actual controlling...
October 29th A-share investment lightning rod │ West Point Pharmaceutical: Shareholders Guotou High-Tech and Hangzhou Chuanghe plan to collectively reduce their shareholding by no more than 3%.
West Point Pharmaceuticals shareholders Guotou High-Tech and Hangzhou Chuanghe plan to collectively reduce their holdings by no more than 3%; Zhejiang Talent Television and Film shareholder Dongyang Juwen plans to reduce their holdings by no more than 2%; Hualv Biotechnology shareholder Gaotou Development plans to reduce their holdings by no more than 5.36%; Haoyuan Medicine shareholders Suxin Fund and Zhenjin Investment plan to collectively reduce their holdings by no more than 3.34%; Zhengzhou Tiamaes Technology incurred a net loss of 52.8719 million yuan in the first three quarters; Guandian Defense stocks may be subject to other risk warnings; China Design Group stated that director Liu Peng received a notice of filing.
Gudian Defense: Third Quarter Report 2024
Third Quarter Report 2024
Guandian Defense (688287.SH) released its performance for the first three quarters, with a net loss of 60.81 million yuan.
GuanDian Defense (688287.SH) disclosed the third quarter report for 2024, with the company achieving revenue of 74...
Observation defense (688287.SH): the net loss in the first three quarters is approximately 60.81 million yuan.
Guandian Defense (688287.SH) announced on October 28th that the total revenue for the first three quarters of 2024 was approximately 74.26 million yuan, a decrease of 56.28% year-on-year; the net income attributable to the company's shareholders was a loss of approximately 60.81 million yuan; with a basic earnings per share loss of 0.16 yuan.
No Data
No Data